Phoenix-based Barrow Neurological Institute was chosen as the inaugural site for the Neuralink PRIME Study.
The study will examine Elon Musk’s Neuralink implant in patients who have quadriplegia due to vertical spinal cord injury or ALS, according to an April 12 news release. Neuralink has already seen one spine patient benefit from the implant so far. The first implantation was completed in January.
The PRIME Study will include patients 22 years and older who have caregivers to support their participation…